Study: COVID-19 shots shown effective in cancer patients up to 4 months later - UPI.com
Transnational cancer research lab | Felsenstein Medical Research Center
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy | npj Breast Cancer
Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry | npj Breast Cancer
oncologischonderzoek.nl -
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
COVID-fighting antibodies last 4+ months in 87% of cancer patients: Israeli MDs | The Times of Israel
First-of-its-kind study in Israel finds that cancer patients are safe for COVID-19 vaccines - EJP
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
COVID vaccine effective for 90% of cancer patients, Israeli study finds | The Times of Israel
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Stotsky Professorship - Jewish Studies Program
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Patients with cancer achieve response to messenger RNA COVID-19 vaccine
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Leadership – CTG-Pharma
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Joelle Hallak - Associate Director, HEOR Real World Evidence (RWE) Analytics - AbbVie | LinkedIn
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
